Halozyme Hypercon Therapeutic Biologics Delivery Patent US12600763B2
Summary
USPTO granted patent US12600763B2 to Halozyme Hypercon, Inc. covering compositions and methods for delivering therapeutic biologics for disease treatment. The patent comprises 18 claims for particles containing therapeutic biologics suspended in a liquid carrier, with priority to an August 2022 filing date.
What changed
USPTO granted patent US12600763B2 to Halozyme Hypercon, Inc. for compositions and methods of delivering therapeutic biologics for disease treatment. The patent covers particles with therapeutic biologics suspended in liquid carriers and contains 18 claims.
This patent grant gives Halozyme Hypercon exclusive IP rights in the United States, which may affect competitors developing similar therapeutic biologics delivery systems. Manufacturers and pharmaceutical companies should review the claims for potential infringement concerns.
What to do next
- Monitor for updates
Archived snapshot
Apr 16, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Compositions and methods for the delivery of therapeutic biologics for treatment of disease
Grant US12600763B2 Kind: B2 Apr 14, 2026
Assignee
Halozyme Hypercon, Inc.
Inventors
Paul Brown, Tyler L Carter, Lyndon Fitzgerald Charles, Jr., Chase Spenser Coffman, Daniel Benjamin Dadon, Lisa Liu, Sadiqua Shadbar, Chaitanya Sudrik, Yi Tang, Shankul Vartak
Abstract
The present disclosure provides compositions and methods for treating a disease or condition in a subject in need thereof, comprising administering to the subject a pharmaceutically effective amount of a composition comprising a plurality of particles comprising at least one therapeutic biologic suspended in a pharmaceutically acceptable liquid carrier.
CPC Classifications
A61K 9/14 A61K 9/10 A61K 9/1623 A61K 9/1652 A61K 45/06 A61K 47/14 A61K 38/00 A61K 39/395 C07K 16/00 A61P 35/00
Filing Date
2022-08-08
Application No.
17883427
Claims
18
Related changes
Get daily alerts for USPTO Patent Grants - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.